...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Expression of bcl-2 and Bax in EGFR-antisense transfected and untransfected glioblastoma cells.
【24h】

Expression of bcl-2 and Bax in EGFR-antisense transfected and untransfected glioblastoma cells.

机译:bcl-2和Bax在EGFR反义转染和未转染的胶质母细胞瘤细胞中的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

Glioblastomas are the most frequent and most malignant astrocytic gliomas. The epidermal growth factor receptor (EGFR) gene is the most frequently amplified and overexpressed in glioblastomas. The expression of bcl-2 and Bax in EGFR-antisense transfected and un-transfected glioblastoma cell line, U87E and U87V was studied by immunohistochemistry and western blotting. Our results show that the expression of Bax was stronger and bcl-2 was weaker in EGFR-antisense transfected cell line than the untransfected control. Bcl-2 and Bax genes are probably involved in the reduction of malignancy of glioblastoma cell caused by the introduction of EGFR-antisense into these tumor cells.
机译:胶质母细胞瘤是最常见,最恶性的星形细胞胶质瘤。表皮生长因子受体(EGFR)基因是胶质母细胞瘤中最常见的扩增和过度表达的基因。通过免疫组织化学和蛋白质印迹研究了EGFR反义转染和未转染的胶质母细胞瘤细胞系U87E和U87V中bcl-2和Bax的表达。我们的结果表明,与未转染的对照相比,在EGFR反义转染的细胞系中Bax的表达更强,bcl-2的表达更弱。 Bcl-2和Bax基因可能与胶质母细胞瘤细胞恶性肿瘤的减少有关,这是由于将EGFR反义引入这些肿瘤细胞中引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号